Agnès Hartemann

Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012

Cécile Billionnet, Delphine Mitanchez, Alain Weill et al. · Diabetologia · 2017 · 587 citations · Full text

The Charcot Foot in Diabetes

Lee C. Rogers, Robert G. Frykberg, David G. Armstrong et al. · Diabetes Care · 2011 · 543 citations · Full text

Rheumatology, Diabetic Charcot Foot, Physiology +14

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

Agnès Hartemann, G. Bensimon, Christine Payan et al. · The Lancet Diabetes & Endocrinology · 2013 · 414 citations

Inflammation, Metabolic Syndrome, Type 1 +9

Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients

Michèlle Rosenzwajg, Guillaume Churlaud, Roberto Mallone et al. · Journal of Autoimmunity · 2015 · 243 citations · Full text

Inflammation, Autoimmune Disease, Low-dose Interleukin-2 Fosters +7

Combinatorial, additive and dose-dependent drug–microbiome associations

Sofia K. Forslund, Rima Chakaroun, Maria Zimmermann‐Kogadeeva et al. · Nature · 2021 · 221 citations · Full text

Dysbiosis, Medicine, Microbiology +4